Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents

Clinical trial NCT01939496 · COMPLETED

Trial details

NCT number

NCT01939496

Sponsor

Janssen Scientific Affairs, LLC

Status

COMPLETED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2013-10-01

Primary completion

2015-04-01

Enrollment

171

View on ClinicalTrials.gov